Medicare Drug price control in the Inflation Reduction Act Moves Forward Except for Insulin
…on unregulated payers. While this might have some intuitive appeal, the contention in the US prescription drug market is inconsistent with standard economic models of profit-maximizing firms. Pharmaceutical companies set…
